Abstract
dc:description.abstractUnforeseen off-target effects in clinical drug trials represent a growing expense in drug development. Biomimetic preclinical models that capture these off-target effects before human trials can maximally reduce these development costs, particularly for cardiotoxicity testing. As preclinical models, lab-grown organoids offer extremely high physiological accuracy yet exhibit high variance and complicated setup. To modulate cardiac organoid activities toward facilitating their development, this thesis developed induced-pluripotent stem cell cardiomyocyte (iPSC-CM) organoids and uses fiber optoacoustic emitters (FOEs) to photoacoustically stimulate cardiomyocyte organoids. As a platform for developing preclinical cardiac models, high-precision photoacoustic control offers a tunable, non-invasive system that offers insights into cell therapies and biomaterials to improve long-term patient outcomes.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Materials Science & Engineering
- Grantor
- Boston University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Sharma, Vikrant
- Advisor dc:contributor.advisor
-
- Yang, Chen
- ORCID dc:identifier.orcid
Subjects
dc:subject × 1Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/48882